Hyperplastic polyps of the colon and rectum - reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma

APMIS

Volumn 123, Issue 4, 2015, Pages 298-304

  Janjua, Huma Gul Rehana ^a   Høgdall, Estrid ^a   Linnemann, Dorte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BRAF; Colorectal cancer; Hyperplastic polyps; Molecular; Serrated lesions

Indexed keywords

B RAF KINASE; K RAS PROTEIN; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADULT; ARTICLE; ASCENDING COLON; BRAF GENE; CANCER RISK; CECUM; COLON POLYP; COLORECTAL CARCINOMA; DESCENDING COLON; DIGESTIVE SYSTEM CANCER; DISEASE CLASSIFICATION; DYSPLASIA; FEMALE; FOLLOW UP; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; ONCOGENE K RAS; PRIORITY JOURNAL; RECTUM; RECTUM POLYP; SESSILE SERRATED LESION; SIGMOID; TRADITIONAL HYPERPLASTIC POLYP; TRANSVERSE COLON; ADENOMA; BIOSYNTHESIS; CLASSIFICATION; COLON; COLORECTAL TUMOR; DNA REPAIR; DNA SEQUENCE; GENETICS; HYPERPLASIA; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; REGISTER; RETROSPECTIVE STUDY;

ADENOMA; BASE SEQUENCE; COLON; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA REPAIR; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MUTATION; PATHOLOGY, MOLECULAR; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RECTUM; REGISTRIES; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 84925307202     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12355     Document Type: Article

References (27)

1. Logan RFA, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut 2012;61:1439-46.
2. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996;110:748-55.
3. Bosman FT. Tumours of the colon and rectum In: Bosnan FT, Carnerio F, Hruban RH, Theise ND, editors. World Health Organization, International Agency for Research on Cancer: World Health Organization Classification of Tumours of the Digestive System, 4th ed. Lyon: IARC, 2010: 131-81.
4. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island nmethylation status. Am J Surg Pathol 2004;28:1452-9.
5. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004;53:1137-44.
6. Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009;62:516-8.
7. Richman SD, Seymour MT, Chambers P, Elliott F, Daly CL, Meade AM, et al. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. J Clin Oncol 2009;27: 5931-7.
8. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003;27:65-81.
9. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006;131:1400-7.
10. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003;119:778-96.
11. Mohammadi M, Garbyal RS, Kristensen MH, Madsen PM, Nielsen HJ, Holck S. Sessile serrated lesion and its borderline variant - variables with impact on recorded data. Pathol Res Pract 2011;207:410-6.
12. Teriaky A, Driman DK, Chande N. Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol 2012;47:178-83.
13. Gurudu SR, Heigh RI, De Petris G, Heigh EG, Leighton JA, Pasha SF, et al. Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol 2010;16:3402-5.
14. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010;63:681-6.
15. Gunia S, Berg T, Gradhand E, Becker S. Knowledge of the anatomical polyp location might bias the pathological classification of histologically equivocal colorectal serrated polyps - a consensus study performed by pathology trainees. Pathol Res Pract 2011;207:116-20.
16. Shimomura T, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Synchronous and subsequent lesions of serrated adenomas and tubular adenomas of the colorectum. Pathobiology 2010;77:273-7.
17. Lazarus R, Juunttila OE, Karttunen TJ, Mäkinen MJ. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 2005;123:349-59.
18. Song SY, Kim YH, Yu MK, Kim JH, Lee JM, Son HJ, et al. Comparison of malignant potential between serrated adenomas and traditional adenomas. J Gastroenterol Hepatol 2007;22:1786-90.
19. Lu FI, van Niekerk de W, Owen D, Tha SP, Turbin DA, Webber DL. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol 2010;3:927-34.
20. Glazer E, Golla V, Forman R, Zhu H, Levi G, Bodenheimer HC Jr. Serrated adenoma is a risk factor for subsequent adenomatous polyps. Dig Dis Sci 2008;53:2204-7.
21. Oono Y, Fu K, Nakamura H, Iriguchi Y, Yamamura A, Tomino Y, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009;54:906-9.
22. Mesteri I, Bayer G, Meyer J, Capper D, Schoppmann SF, von Deimling A, et al. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E. Mod Pathol 2014;27:135-44.
23. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
24. De Roock W, Piessevaux H, De Schutter J, Janssens M, De Hertogh G, Personeni N, et al. KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol 2008;19:508-15.
25. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993;104:57-64.
26. Khoo JJ, Gunn A, Peh SC. Pattern of hMLH1, hMSH2 and hMSH6 expression and clinical characteristics in a sample of Malaysian colorectal carcinoma cases. Malays J Pathol 2013;35:45-57.
27. Danish Cancer Registry. Available at: www.ssi.dk (Accessed 17 Nov 2014).